We have found in the past 4 years several genes that affect stem cell behaviors: bcl-2 inhibits programmed cell death, and increases HSC numbers and competitiveness in vivo; Wnt 3A and beta-catenin stimulate phenotypic HSC expansion in vitro, and these cells give LTMR upon transplantation; axin (an inhibitor of beta-catenin) blocks HSC proliferation in response to a variety of cytokines; bmi-1 (from Mike Clarke), whose absence prevents fetal liver hematopoiesis spreading to prenatal and postnatal bone marrow; and hTERT, which enforces HSC telomere maintenance through serial HSC transplants. We have begun the analysis of a number of genes with relative or absolute increased expression in LT-HSC vs. progeny (including ST-HSC). Here we plan to test whether our Wnt/beta -catenin/axin results define a manipulatable pathway for HSC self-renewal, and whether other identified (or newly identified) LT-HSC genes or leukemia translocated genes play roles in HSC self-renewal or other HSC behaviors. We plan to expand dramatically our efforts to find, catalogue, and determine cell lineage expression of all LT-HSC (and ST-HSC/MPP and CLP and CMP) transcripts. Finally, using tet-regulatable lentivirus vectors, we will test candidate genes by transfection of HSC, retain aliquots for in vivo hematopoiesis analyses, and co-transplant the rest to allow the whole animal select the most competitive clones. Recloning and retransfection will further limit the genes likely to play key roles in self-renewal. Recloning and retransfection will further limit the genes likely to play key roles in self-renewal, etc. ES cell complete or conditional knock-outs will help define the role of the genes in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
2P01DK053074-06
Application #
6583553
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2002-09-01
Project End
2007-08-31
Budget Start
Budget End
Support Year
6
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Sun, Bingyun; Ma, Li; Yan, Xiaowei et al. (2013) N-glycoproteome of E14.Tg2a mouse embryonic stem cells. PLoS One 8:e55722
Bockhorn, Jessica; Yee, Kathy; Chang, Ya-Fang et al. (2013) MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion. Breast Cancer Res Treat 137:373-82
Heffner, Garrett C; Clutter, Matthew R; Nolan, Garry P et al. (2011) Novel hematopoietic progenitor populations revealed by direct assessment of GATA1 protein expression and cMPL signaling events. Stem Cells 29:1774-82
Yan, Xiaowei; Ma, Li; Yi, Danielle et al. (2011) A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations. Proc Natl Acad Sci U S A 108:1591-6
Forsberg, E Camilla; Passegué, Emmanuelle; Prohaska, Susan S et al. (2010) Molecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells. PLoS One 5:e8785
Jaiswal, Siddhartha; Chao, Mark P; Majeti, Ravindra et al. (2010) Macrophages as mediators of tumor immunosurveillance. Trends Immunol 31:212-9
Inaba, Mayu; Yuan, Hebao; Salzmann, Viktoria et al. (2010) E-cadherin is required for centrosome and spindle orientation in Drosophila male germline stem cells. PLoS One 5:e12473
Ooi, A G Lisa; Karsunky, Holger; Majeti, Ravindra et al. (2009) The adhesion molecule esam1 is a novel hematopoietic stem cell marker. Stem Cells 27:653-61
Papathanasiou, Peter; Attema, Joanne L; Karsunky, Holger et al. (2009) Evaluation of the long-term reconstituting subset of hematopoietic stem cells with CD150. Stem Cells 27:2498-508
Majeti, Ravindra; Becker, Michael W; Tian, Qiang et al. (2009) Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc Natl Acad Sci U S A 106:3396-401

Showing the most recent 10 out of 38 publications